CANIHELMIN PLUS
CANIHELMIN PLUS
Authorised
- Praziquantel
- Pyrantel embonate
- Febantel
Product identification
Medicine name:
CANIHELMIN PLUS
Canihelmin plus, 50+144+150mg, Tableta
Active substance:
- Praziquantel
- Pyrantel embonate
- Febantel
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Praziquantel50.00/milligram(s)1.00Tablet
-
Pyrantel embonate144.00/milligram(s)1.00Tablet
-
Febantel150.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AA51
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Czechia
Available in:
-
Czechia
Package description:
- cardboard box containing 10 strips of 10 tablets
- cardboard box containing 2 strips of 10 tablets
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Genera d.d.
Marketing authorisation date:
Manufacturing sites for batch release:
- GENERA d.d.
Responsible authority:
- Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
- 96/070/16-C
Date of authorisation status change:
Reference member state:
-
Spain
Procedure number:
- ES/V/0245/001
Concerned member states:
-
Bulgaria
-
Czechia
-
Romania
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 22/12/2023
Czech (PDF)
Published on: 13/05/2024
Combined File of all Documents
English (PDF)
Download Published on: 24/07/2025
eu-PUAR-esv0245001-dcp-canihelmin-plus-en.pdf
English (PDF)
Download Published on: 22/12/2023